COMMUNIQUÉS West-GlobeNewswire

resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update
14/08/2019
– Quarter highlighted by initiation and early completion of enrollment of Phase 3 PROTECTOR 1 trial; topline data expected by early first quarter of 2020 – BOSTON, Aug. 14, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ( [...]
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
14/08/2019
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today reported financial results [...]
Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress
14/08/2019
Enrollment on track in the TOPAZ Phase 2 clinical trial of SRK-015 in patients with Type 2 and Type 3 Spinal Muscular Atrophy for preliminary PK/PD results by year-end Presented positive final results from the Phase 1 [...]
Italian Achromatopsia Association Increases Global Awareness of Achromatopsia, a Rare Genetic Eye Disease, With an Expedition to Pingelap, the Island of the Color Blind
14/08/2019
TRENTO, Italy, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The Italian Achromatopsia Association (IAA) today announced that it is organizing a trip to Pingelap, a remote Micronesian atoll in the South Pacific, also known as the “ [...]
Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.
14/08/2019
VANCOUVER, British Columbia, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“ Sunens [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
14/08/2019
NEWTOWN, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on [...]
Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
14/08/2019
– Additional patient dosed at 2E14 vg/kg in second cohort of IGNITE DMD trial – – Study protocol amended to expedite clinical execution of SGT-001 – – Recent $60M capital raise extends runway into the fourth quarter of [...]
Ogilvy Health Further Cultivates Creative Community With Multiple Promotions
14/08/2019
PARSIPPANY, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health, part of Ogilvy ( www.ogilvy.com ), today announced the advancement of seven creative team members across the agency’s New Jersey and New York offices. [...]
Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
14/08/2019
IND Active for Phase 1/2 Trial of PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations Successful $125.0 Million Initial Public Offering Completed to Support Program Advancement and Expansion NEW YORK, Aug. [...]
PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting with the FDA and Alignment on a Single, Non-Randomized Phase 3 Trial to Support BLA Submission for PB2452
14/08/2019
Clinical development plan and Accelerated Approval regulatory path confirmed Phase 3 trial to initiate in the first quarter of 2020 and intended to support both major bleeding and surgery indications Conference call and [...]
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
14/08/2019
--Phase 3 Topline Data anticipated in the fourth quarter-- -- NDA filings expected in first quarter of 2020-- DUBLIN, Ireland and CHICAGO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a [...]
Adynxx Reports Second Quarter 2019 Financial Results
14/08/2019
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics [...]
JSC Olainfarm will add senior level management with international experience in pharmacy. Lauris Macijevskis continues to work on the Board of JSC Olainfarm
14/08/2019
In order to strengthen the management team of JSC Olainfarm, the Supervisory Council has decided to appoint a new candidate with international experience in pharmacy for the position of the Chairman of the Board of JSC [...]
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
14/08/2019
Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET) SUMMARY January-June 2019 Net sales EUR 5.0 million (EUR 4.9 million) Net sales grew by 1% compared to H1/2018 Operative EBITDA EUR +0.4 [...]
Demant A/S: Interim Report 2019
14/08/2019
Company announcement no 2019-07 14 August 2019 Interim Report 2019 8% growth for the Group – recent product launches drive growth acceleration into H2 12% unit growth drives market share gains in hearing aid wholesale [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
13/08/2019
Company Release no. 13/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 August 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results
13/08/2019
Strong Quarter-Over-Quarter Performance 26% Increase in U.S. Product Revenue 46% Increase in Dermatology Revenue 23% Reduction in Operating Expenses PETALUMA, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Sonoma [...]
Synergy CHC Corp. Announces Second Quarter 2019 Results
13/08/2019
Westbrook, Maine, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30th, [...]
KemPharm Reports Second Quarter 2019 Results
13/08/2019
CELEBRATION, Fla., Aug. 13, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and [...]

Pages